Search for: "Peter Anda"
Results 1 - 20
of 49
Sorted by Relevance
|
Sort by Date
4 Nov 2014, 9:58 pm
Noonan -- Late last week, District Court Judge Peter Sheridan (D.N.J.) dismissed with prejudice the complaint for antitrust injury by the so-called "End Payor Class Purchasers" against the parties in previous ANDA litigation in the case styled In re Lipitor Antitrust Litigation (Order). [read post]
9 Oct 2008, 11:16 pm
until Anda Management, LLC v. [read post]
3 Apr 2013, 4:45 am
District Court for the District of New Jersey (Judge Peter G. [read post]
12 Oct 2018, 2:09 pm
¿De dónde le sale al cadáver que anda su arrogancia y sentirse como dios? [read post]
17 Aug 2016, 7:34 pm
Professor Peter Menell (Berkeley) has lead the multi-party effort in cooperation with the Federal Judicial Center. [read post]
26 Jul 2019, 4:12 pm
This week in Other Barks & Bites: a series of bills introduced into Congress aim to improve prospects for minority inventors, eliminate compulsory copyright licenses in broadcast TV and reduce patent challenges against generic drugmakers; the Federal Circuit decides that there is no functionality in the aesthetic appeal of a design patent; FBI Director Wray testifies on about 1,000 IP theft probes pointing back to Chinese entities; France is the first EU country to adopt the Copyright Directive;… [read post]
12 Dec 2006, 9:56 pm
The next day, Judge Peter G. [read post]
20 Sep 2021, 1:23 am
Based on this significant gap, there is far more case law in the ANDA than the aBLA context. [read post]
11 Jan 2022, 6:04 am
(“MPI”) submitted an ANDA from West Virginia, seeking to market a generic version of pomalidomide. [read post]
20 Sep 2021, 1:23 am
Based on this significant gap, there is far more case law in the ANDA than the aBLA context. [read post]
4 Mar 2011, 8:17 am
The prosecuting law firm was Knobbe, Martens, Olson & Bear LLP .The inventors are listed as: Dunworth; Peter D. [read post]
1 Jan 2007, 7:45 pm
Reddy’s, and Teva) filed an ANDA and Lilly responded with a complaint in the Southern District of Indiana. [read post]
4 Feb 2007, 8:45 pm
Via Patent Circle, Abraxis, Orchid, and Sandoz have filed citizen petitions in support of their ANDAs for generic versions of Wyeth's Zosyn. [read post]
2 Aug 2007, 6:25 am
Peters was of the opinion that the presence of a government tenant could cloud a property’s status and make it more akin to a “public forum. [read post]
23 Sep 2009, 4:00 am
(Intellectual Property Watch) Products Coversyl (Perindopril) - Australia: FCA decision a reminder to review issued patent claims in view of newly emerged prior art before filing suit: Apotex Pty Ltd v Les Laboratoires Servier (Patent Baristas) Duac (Clindamycin, Benzoyl) – Perrigo acquires KV Pharmaceutical’s first to file ANDA for generic Duac gel (GenericsWeb) Mircera (Recombinant erythropoietin) – US: CAFC: Section 121 ‘safe… [read post]
3 Oct 2018, 5:55 am
Peter C. [read post]
26 Dec 2006, 10:56 pm
Dailey Yesterday the Federal Circuit affirmed Eli Lilly's April 2005 district court victory in its dispute with ANDA filers Zenith Goldline (now IVAX), Teva, and Dr. [read post]
14 Dec 2007, 1:00 am
: (Patent Prospector) PharmaAggregate launches new online presence: (MaRS Blog - Innovation and Commercialization in Canada)Japan Plans Generic Drug Incentives to Cut Down Medical Costs: (MedIndia), Interesting commentary and article on generic/ innovator company patent settlements: (Generic Pharmaceuticals & IP), Global trends in commencement of patent actions by innovators: (Generic Pharmaceuticals & IP), Is marketing and not … [read post]
29 Feb 2012, 11:52 am
Previous explorations to create a third category of drugs have petered out. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
